Dr Cath O’Neill Recognised as One of the Top 50 Female Leaders in UK Healthcare

Dr Cath O’Neill, CEO of SkinBioTherapeutics, commented: “I am delighted that we now have all three aspects of our human study scheduled. Data from the two initial tests is expected in October 2018, and data from

SkinBiotherapeutics (LON:SBTX) CEO Catherine O’Neill presenting at the shares and AJ Bell investors evening in Edinburgh.  

First, let’s briefly talk about the microbiome. The gut microbiome refers to the trillions of bacteria that live within our gastrointestinal tracts. If you were to collectively bunch them all up into a ball, it would

Results of pre-clinical and early clinical trials conducted by investigators at the National Institutes of Health showing the effectiveness of using bacteria to treat eczema are paving the way for further study into the potential for

Dr Cath O’Neill, CEO of SkinBioTherapeutics, commented: “Demonstrating the extended stability of the cream formulation was a key step to commencing the human study. This remains on track to start this month.” The information communicated within

Increasing interest in the skin microbiome as a beauty concept is beginning to challenge perceptions about the role of bacteria in the skin. But what does this really mean for the personal care industry? A microbiome

Dr Cath O’Neill, CEO of SkinBioTherapeutics, commented: “The progress we’ve made so far in manufacturing and freeze-drying the lysate is very encouraging. The current formulation is undergoing extended stability studies in preparation for the human study.”

Like your gut, your skin also has a complex system of bacteria and fungi living on its surface. “It sounds weird and scary, but it’s actually good for you,” says Sarvenaz Zand, M.D., a dermatologist based

If you have found your way to this story, then there is a good chance you’re feeling the itch. Dyshidrotic Eczema is a common form of eczema that can crop up as crazy itchy blisters on

Microbes on the surface of the skin help the immune system to respond to injury and heal wounds. Immunity research have historically focused on the response to pathogens and inflammation, and so relatively little is known

News recently hit the headlines, in both  the British Medical Journal and the media, that eczema has joined the list of conditions which are linked to heart disease and stroke. How could that be? How is

Dr Catherine O’Neill, CEO of SkinBioTherapeutics, commented: “Ethics approval is a prerequisite for human clinical trials and therefore required before our human study can commence. The procedural amendments we need to make to the paperwork are

Before this spring, I’d only heard about eczema (the most common type of which is known as atopic dermatitis) in lotion commercials I’d seen on the TV, and to be completely honest, I didn’t really know

If you’ve ever had a breakout, you’ve likely tried to dry those suckers up with bacteria-killing washes and spot treatments. You know, because conventional wisdom (and lots of research) has shown that zits, particularly the big painful

SkinBioTherapeutics (LON:SBTX) CEO Dr Cath O’Neill worked in the field of gastroenterology, investigating the effect of probiotics on the intestinal barrier function, an area which had already seen significant commercial success through health foods and yoghurt

The first ever CosmeticsDesign Summit will take place in June 2019 and this unique face-to-face event will focus on one of the industry’s biggest trends – the skin microbiome. A full two-day conference, ‘Skin Microbiome Innovation’​ ​will be

The gut gets the majority of the attention when we talk about the microbiome (even though your mouth has a vast microbiome as well!). The digestive system is home to trillions of organisms that can affect the body,